| Schedule of Term Loans and Financing Activity |
During the periods covered by this report, the base rates, margins and effective interest rates were as follows for the periods indicated: | | | | | | | | | | Period | Base Rate plus Margin | Effective Rate | | | | As of December 31, 2025 | SOFR plus 2.25% Prime Rate plus 1.25% | 6.07% 8.0% | As of June 30, 2026 | SOFR plus 2.0% Prime Rate plus 1.0% | 5.7% 7.8% |
As of June 30, 2026 and December 31, 2025, our term loan debt and other debt obligations, excluding finance lease liabilities, were as follows (in thousands): | | | | | | | | | | | | | | June 30,
2026 | | December 31,
2025 | | Barclays Term Loans collateralized by RadNet's tangible and intangible assets | $ | 1,205,604 | | | $ | 961,119 | | | Discount on Barclays Term Loans | (11,283) | | | (11,759) | | | Truist Term Loan Agreement collateralized by NJIN's tangible and intangible assets | 118,125 | | | 123,750 | | | Discount on Truist Term Loan Agreement | (330) | | | (462) | | | | | | Equipment notes payable at 2.7% to 7.2%, due through 2029, collateralized by medical equipment | 17,603 | | | 17,271 | | | Other notes payable, due through 2036 | 2,812 | | | — | | | Total debt obligations, excluding finance lease liabilities | 1,332,531 | | | 1,089,919 | | | Less: current portion | (30,669) | | | (25,424) | | | Long term portion of debt obligations | $ | 1,301,862 | | | $ | 1,064,495 | |
The following table reconciles the debt obligations presented above to total debt obligations, including finance lease liabilities (in thousands): | | | | | | | | | | | | | June 30,
2026 | | December 31,
2025 | | Total debt obligations, excluding finance lease liabilities | $ | 1,332,531 | | | $ | 1,089,919 | | | Short-term finance lease liability* | 1,332 | | | — | | | Long-term finance lease liability | 4,288 | | | $ | — | | Total debt obligations, including finance lease liabilities | $ | 1,338,151 | | | $ | 1,089,919 | |
*The short-term finance lease liability is included in “Accounts payable, accrued expenses and other” in the accompanying condensed consolidated balance sheets.
|